Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery

Clinical trial NCT06575049 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06575049
Sponsor: Seoul National University Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Post-Operative Hematoma Seroma as Procedural Complication Post-Op Complication

Start date: 2025-05-01
Primary completion: 2025-08-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.